Supplements

Home » Supplements

Sylvester Researchers Report Prevention of Lethal Prostate Cancer with 4-MU Dietary Supplement

In a groundbreaking laboratory study, a research team at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has found that a non-toxic oral agent that is also consumed as an over-the-counter dietary supplement in Europe and Asia for improving liver health, is highly effective in both preventing and treating prostate cancer. Additionally the agent was able to halt the metastatic spread of the disease. “We found that 4-methylumbelliferone (4-MU) was able to block a key signaling pathway that triggers the development, growth and metastasis of prostate cancer,” said the study’s principal investigator Vinata B. Lokeshwar, […]

Sylvester Researchers Report Prevention of Lethal Prostate Cancer with 4-MU Dietary Supplement Read More »

Vitamin D may keep low-grade prostate cancer from becoming aggressive

Taking vitamin D supplements could slow or even reverse the progression of less aggressive, or low-grade, prostate tumors without the need for surgery or radiation, says Bruce Hollis, Ph.D., who is at the Medical University of South Carolina. Preliminary results from this study indicate that many of the men who received vitamin D showed improvements in their prostate tumors, whereas the tumors in the placebo group either stayed the same or got worse. Also, vitamin D caused dramatic changes in the expression levels of many cell lipids and proteins, particularly those involved in inflammation. “Cancer is associated with inflammation, especially

Vitamin D may keep low-grade prostate cancer from becoming aggressive Read More »

Dietary supplements linked to increased cancer risk

Consumers are always looking for ways to minimize their cancer risk, which is one reason why many turn to over-the-counter vitamin and mineral supplements. But new research finds that while companies promote dietary supplements for their cancer-prevention benefit, some may end up doing more harm than good. Dr. Tim Byers, director for cancer prevention and control at the University of Colorado Cancer Center, conducted a meta-analysis of two decades worth of research — 12 trials that involved more than 300,000 people — and found a number of supplements actually made a person much more likely to develop certain types of

Dietary supplements linked to increased cancer risk Read More »

More Evidence of Harm From Selenium in Prostate Cancer

A new analysis has found that men diagnosed with nonmetastatic prostate cancer who consumed more than 140 μg a day of supplemental selenium had over a two-and-a-half–fold excess risk for death from prostate cancer compared with nonsupplement users. On the other hand, there was a modest 12% inverse association between selenium supplementation and the risk for overall mortality (HR, 0.88) among men who took 140 μg of a selenium supplement or more per day compared with those who didn’t use supplements. Read the article.

More Evidence of Harm From Selenium in Prostate Cancer Read More »

Advances in Prostate Cancer: 2014

The year 2014 has again provided important developments in the area of prostate cancer. New data and new treatments span the spectrum of prostate cancer management, from prevention and screening to optimal strategies for localized, locally advanced, and metastatic disease. Read the article.  (Free Medscape account required.)

Advances in Prostate Cancer: 2014 Read More »

Managing bone health in patients with prostate cancer

Department of Surgery, University of Toronto, Humber River Hospital, Toronto, Ontario, Canada BARKIN J. How I Do It: Managing bone health in patients with prostate cancer. Can J Urol 2014;21(4): 7399-7403. Urologists have two scenarios where they have to address bone loss or increased risk of fractures in men with prostate cancer. In the first setting, a patient who has been started on androgen deprivation therapy may develop cancer-treatment-induced bone loss. In the second setting, a patient’s prostate cancer may have metastasized to the bone. This article describes six steps to manage bone health in patients diagnosed with prostate cancer

Managing bone health in patients with prostate cancer Read More »

Aspirin Eases Genitourinary Toxicity from Prostate Cancer Radiotherapy

Low-dose aspirin use is independently associated with decreased acute genitourinary (GU) toxicity in patients undergoing radiotherapy for prostate cancer (PCa), researchers reported at the American Society for Radiation Oncology 56th annual meeting in San Francisco. Read the article.

Aspirin Eases Genitourinary Toxicity from Prostate Cancer Radiotherapy Read More »

B2G2 component of grape seed extract induces apoptosis in prostate cancer cells

A University of Colorado Cancer Center study published online ahead of print in the journal Nutrition and Cancer describes the laboratory synthesis of the most active component of grape seed extract, B2G2, and shows this synthesized compound induces the cell death known as apoptosis in prostate cancer cells while leaving healthy cells unharmed. Read the article.

B2G2 component of grape seed extract induces apoptosis in prostate cancer cells Read More »

Scroll to Top